FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1623737811> ?p ?o ?g. }

• W1623737811 endingPage "95" @default.
• W1623737811 startingPage "88" @default.
• W1623737811 abstract "Study Type – Therapy (symptom prevalence) Level of Evidence 2a What's known on the subject? and What does the study add? Largest survey ever conducted evaluating the management of AUR in real life practice in a wide range of health care systems. It shows that urethral catheterization followed by a TWOC has become a standard worldwide and that α 1 ‐blockade prior to TWOC doubles the chances of success. It also evidences important differences (hospitalization rate, duration of catheterization ...) between countries/regions reflecting lack of guidelines. This large survey also clearly identifies predictors of TWOC failure. OBJECTIVES To evaluate the management of acute urinary retention (AUR) associated with benign prostatic hyperplasia (BPH) in real‐life practice. To identify predictors of successful trial without catheter (TWOC). MATERIALS AND METHODS In all, 6074 men catheterized for painful AUR were enrolled in a prospective, cross‐sectional survey conducted in public and private urology practices in France, Asia, Latin America, Algeria and the Middle East. Patient clinical characteristics, type of AUR and its management (type of catheterization, hospitalization, TWOC, use of α 1 ‐blockers, immediate or elective surgery) and adverse events observed during the catheterization period were recorded. Predictors of TWOC success were also analysed by multivariate regression analysis with stepwise procedure. RESULTS Of the 6074 men, 4289 (71%) had a spontaneous AUR and 1785 (29%) had a precipitated AUR, mainly as the result of loco‐regional/general anaesthesia (28.5%) and excessive alcohol intake (18.2%). Presence of BPH was revealed by AUR in 44% of men. Hospitalization for AUR varied between countries, ranging from 1.7% in Algeria to 100% in France. A urethral catheter was inserted in most cases (89.8%) usually followed by a TWOC (78.0%) after a median of 5 days. Overall TWOC success rate was 61%. Most men (86%) received an α 1 ‐blocker (mainly alfuzosin) before catheter removal with consistently higher TWOC success rates, regardless of age and type of AUR. Multivariate regression analysis confirmed that α 1 ‐blocker before TWOC doubled the chances of success (odds ratio 1.92, 95% CI 1.52–2.42, P < 0.001). Age ≥70 years, prostate size ≥50 g, severe lower urinary tract symptoms, drained volume at catheterization ≥1000 mL and spontaneous AUR favoured TWOC failure. Catheterization >3 days did not influence TWOC success but was associated with increased morbidity and prolonged hospitalization for adverse events. In the case of TWOC failure, 49% of men were recatheterized and had BPH surgery and 43.5% tried another TWOC with a success rate of 29.5%. Elective surgery was preferred to immediate surgery. CONCLUSIONS TWOC has become a standard practice worldwide for men with BPH and AUR. In most cases, an α 1 ‐blocker is prescribed before TWOC and significantly increases the chance of success. Prolonged catheterization is associated with an increased morbidity." @default.
• W1623737811 created "2016-06-24" @default.
• W1623737811 creator A5000485718 @default.
• W1623737811 creator A5004846977 @default.
• W1623737811 creator A5017860678 @default.
• W1623737811 creator A5028149391 @default.
• W1623737811 creator A5058689509 @default.
• W1623737811 creator A5075188714 @default.
• W1623737811 creator A5082347412 @default.
• W1623737811 date "2011-11-25" @default.
• W1623737811 modified "2023-10-18" @default.
• W1623737811 title "Management of acute urinary retention: a worldwide survey of 6074 men with benign prostatic hyperplasia" @default.
• W1623737811 cites W1532834942 @default.
• W1623737811 cites W1587851226 @default.
• W1623737811 cites W1597543603 @default.
• W1623737811 cites W1974802657 @default.
• W1623737811 cites W1982814353 @default.
• W1623737811 cites W1982951328 @default.
• W1623737811 cites W1990926980 @default.
• W1623737811 cites W2001118874 @default.
• W1623737811 cites W2005518644 @default.
• W1623737811 cites W2011962188 @default.
• W1623737811 cites W2017721657 @default.
• W1623737811 cites W2030698665 @default.
• W1623737811 cites W2061191313 @default.
• W1623737811 cites W2066111926 @default.
• W1623737811 cites W2099501142 @default.
• W1623737811 cites W2130374121 @default.
• W1623737811 cites W2156802695 @default.
• W1623737811 cites W2166791304 @default.
• W1623737811 cites W4229487303 @default.
• W1623737811 doi "https://doi.org/10.1111/j.1464-410x.2011.10430.x" @default.
• W1623737811 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3272343" @default.
• W1623737811 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22117624" @default.
• W1623737811 hasPublicationYear "2011" @default.
• W1623737811 type Work @default.
• W1623737811 sameAs 1623737811 @default.
• W1623737811 citedByCount "87" @default.
• W1623737811 countsByYear W16237378112012 @default.
• W1623737811 countsByYear W16237378112013 @default.
• W1623737811 countsByYear W16237378112014 @default.
• W1623737811 countsByYear W16237378112015 @default.
• W1623737811 countsByYear W16237378112016 @default.
• W1623737811 countsByYear W16237378112017 @default.
• W1623737811 countsByYear W16237378112018 @default.
• W1623737811 countsByYear W16237378112019 @default.
• W1623737811 countsByYear W16237378112020 @default.
• W1623737811 countsByYear W16237378112021 @default.
• W1623737811 countsByYear W16237378112022 @default.
• W1623737811 countsByYear W16237378112023 @default.
• W1623737811 crossrefType "journal-article" @default.
• W1623737811 hasAuthorship W1623737811A5000485718 @default.
• W1623737811 hasAuthorship W1623737811A5004846977 @default.
• W1623737811 hasAuthorship W1623737811A5017860678 @default.
• W1623737811 hasAuthorship W1623737811A5028149391 @default.
• W1623737811 hasAuthorship W1623737811A5058689509 @default.
• W1623737811 hasAuthorship W1623737811A5075188714 @default.
• W1623737811 hasAuthorship W1623737811A5082347412 @default.
• W1623737811 hasBestOaLocation W16237378111 @default.
• W1623737811 hasConcept C126322002 @default.
• W1623737811 hasConcept C126894567 @default.
• W1623737811 hasConcept C197934379 @default.
• W1623737811 hasConcept C2777562237 @default.
• W1623737811 hasConcept C2779091618 @default.
• W1623737811 hasConcept C71924100 @default.
• W1623737811 hasConceptScore W1623737811C126322002 @default.
• W1623737811 hasConceptScore W1623737811C126894567 @default.
• W1623737811 hasConceptScore W1623737811C197934379 @default.
• W1623737811 hasConceptScore W1623737811C2777562237 @default.
• W1623737811 hasConceptScore W1623737811C2779091618 @default.
• W1623737811 hasConceptScore W1623737811C71924100 @default.
• W1623737811 hasIssue "1" @default.
• W1623737811 hasLocation W16237378111 @default.
• W1623737811 hasLocation W16237378112 @default.
• W1623737811 hasLocation W16237378113 @default.
• W1623737811 hasLocation W16237378114 @default.
• W1623737811 hasOpenAccess W1623737811 @default.
• W1623737811 hasPrimaryLocation W16237378111 @default.
• W1623737811 hasRelatedWork W1550685264 @default.
• W1623737811 hasRelatedWork W1977496497 @default.
• W1623737811 hasRelatedWork W2008649453 @default.
• W1623737811 hasRelatedWork W2027325131 @default.
• W1623737811 hasRelatedWork W2323333738 @default.
• W1623737811 hasRelatedWork W2917438197 @default.
• W1623737811 hasRelatedWork W3029504619 @default.
• W1623737811 hasRelatedWork W3032769639 @default.
• W1623737811 hasRelatedWork W4313382530 @default.
• W1623737811 hasRelatedWork W4383896537 @default.
• W1623737811 hasVolume "109" @default.
• W1623737811 isParatext "false" @default.
• W1623737811 isRetracted "false" @default.
• W1623737811 magId "1623737811" @default.
• W1623737811 workType "article" @default.